factsheet
From the Lab to the Jab
From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.
Project
An African-Led Movement for Prevention Research
The Coalition to Accelerate & Support Prevention Research (CASPR) project focuses on developing and sustaining an Africa-centered network dedicated to accelerating biomedical HIV prevention research, and advancing equitable access to proven HIV prevention products.
Amidst a shrinking envelope of global resources for the overall HIV response, the HIV prevention field is challenged with scaling up proven prevention options while sustaining momentum in research and development (R&D) of next-generation HIV prevention products. People need a rich array of effective choices that work for their life circumstances, and urgently.
But as we’ve learned from past experience, once products are shown to work, programs, policies and funding must match the needs of affected communities and overcome the barriers that have blocked or slowed access in the past, while at the same time, accelerating R&D of the prevention pipeline.
CASPR’s many initiatives take on these challenges.
The Coalition to Accelerate & Support Prevention Research (CASPR), designed by AVAC in collaboration with key partners and supported by USAID, is a set of partnerships and activities focused on accelerating biomedical HIV prevention research.
CASPR is an Africa-led coalition of 13+ partners, supported by AVAC, working together to change how HIV prevention is pursued and delivered. CASPR activities are focused primarily in key African countries with the highest burden of new HIV infections, and where biomedical HIV prevention research is ongoing or planned. The Coalition:
CASPR has created a platform to support, expand and advance African-centered leadership on the crucial advocacy that’s needed to ensure a robust pipeline of prevention options reach the people who need them most.
In six years, the CASPR project has:
CASPR information is also available in a PDF project brief version. Download here.
For more information about CASPR, contact Breanne Lesnar at breanne@avac.org.
factsheet
From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.
report
The purpose of this newsletter is to inform and engage CASPR partners and other stakeholders about the progress, achievements, challenges and lessons learned from CASPR initiatives.
factsheet
CASPR focuses on developing and sustaining an Africa-centered network dedicated to accelerating biomedical HIV prevention research, and advancing equitable access to proven HIV prevention products.
This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.